Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › IMVT

SILVERARC CAPITAL MANAGEMENT, LLC position in IMVT

IMMUNOVANT INC · Health Care

SILVERARC CAPITAL MANAGEMENT, LLC reported holding 624,055 shares of IMVT (IMMUNOVANT INC) in its Q3 2026 13F filing — a position valued at US$21.1M, representing 2.69% of its reported portfolio and ranking #10 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed IMVT holdings in 5 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)624.05K sh
Reported value held$21.08M
Portfolio Weight2.69%
First reportedQ4 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SILVERARC CAPITAL MANAGEMENT, LLC's IMVT position evolved

SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in IMVT in Q4 2023 at 20,000 shares (US$843K). The position peaked in Q2 2026 at 619,096 shares, worth US$23.9M. Across 5 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 624,055 shares valued at US$21.1M — an increase of 4,959 shares quarter over quarter.. Notable position changes include a 49% increase in Q2 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 20.00K $842.60K New
Q3 2025 50.00K $806.00K New
Q1 2026 414.24K $10.29M New
Q2 2026 619.10K $23.85M Add
Q3 2026 624.05K $21.08M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMVT and 13F data

IMVT (IMMUNOVANT INC) is a Health Care company. 38 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMVT

All IMVT fund holders →

FAQ

How long has SILVERARC CAPITAL MANAGEMENT, LLC held IMVT?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed IMVT holdings in 5 of the last 12 reported quarters, going back to Q4 2023.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in IMVT?

As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 624.05K shares of IMVT (IMMUNOVANT INC), valued at $21.08M, representing 2.69% of its reported portfolio and ranking #10.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling IMVT?

In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in IMVT. The position peaked in Q2 2026 at 619.10K shares.

Which other funds hold IMVT?

Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.